San Diego, California
CNS medication trials in San Diego, CA
25 CNS medication studies are recruiting participants at sites in San Diego as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Diego at a glance
- 25 studies are recruiting at a site in San Diego.
- By phase: Phase 2 (8), Phase 3 (15), Phase 4 (2).
- By sponsor: industry (23), university, hospital or other (2).
- By research area: Depression (11), Schizophrenia (7), Migraine (4), Epilepsy (2), Bipolar Disorder (1).
- Most recent update to one of these records: November 12, 2026.
Depression studies recruiting in San Diego
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- Kadima Neuropsychiatry Institute
- Registry record
- NCT07002034 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- Kadima Neuropsychiatry Institute
- Registry record
- NCT07592689 · updated
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Artemis Institute for Clinical Research
- Registry record
- NCT07716098 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Registry record
- NCT07621237 · updated
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT07553637 · updated
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07484217 · updated
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07300969 · updated
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07105111 · updated
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06786624 · updated
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Phase 4
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT06223880 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in San Diego, CA on ClinicalTrials.gov.
Schizophrenia studies recruiting in San Diego
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07114874 · updated
52-week Open Label Safety-Tolerability Study
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Synergy San Diego
- Registry record
- NCT07369154 · updated
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06963034 · updated
Randomized Withdrawal Study in Patients With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06961968 · updated
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
- Phase 3
- Ages 16 to 30
- All sexes
- Sponsor
- University of California, San Diego
- Study site
- University of California, San Diego
- Registry record
- NCT04411225 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in San Diego, CA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in San Diego
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07288320 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in San Diego, CA on ClinicalTrials.gov.
Epilepsy studies recruiting in San Diego
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
- Phase 2
- Ages 2 to 60
- All sexes
- Sponsor
- Scripps Translational Science Institute
- Study site
- Scripps Research Translational Institute
- Registry record
- NCT07847918 · updated
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Phase 3
- From 1 day, up to 18 years
- All sexes
- Sponsor
- Praxis Precision Medicines
- Study site
- Praxis Research Site
- Registry record
- NCT07019922 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in San Diego, CA on ClinicalTrials.gov.
Migraine studies recruiting in San Diego
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Paradigm Clinical Research Centers, LLC
- Registry record
- NCT07816367 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Acclaim Clinical Research
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Acclaim Clinical Research
- Registry record
- NCT07674654 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Paradigm Clinical Research - San Diego /ID# 269608
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in San Diego, CA on ClinicalTrials.gov.
Ask about studies near San Diego
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
168 studies recruiting across 83 cities.
Los Angeles
37 studies recruiting.
Orange
35 studies recruiting.
Anaheim
25 studies recruiting.
Walnut Creek
24 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections